FDA fast-tracks VS-7375, an oral KRAS G12D inhibitor, opening new hope for pretreated advanced NSCLC and fueling pivotal ...

A new wave of cancer treatments is looking promising for the future of oncologic care. The ovarian cancer drug RC88, which is made by the Chinese biopharmaceutical company RemeGen, received FDA ...

Verastem Oncology received fast track designation from the Food and Drug Administration for a potential treatment for non-small cell lung cancer.

VS-7375 is an oral pill designed to block the mutated KRAS G12D protein in both its active and inactive states. ・The company is already testing VS-7375 in multiple trials. ・Verastem already holds Fast ...

The 2024 Australian of the Year Professor Richard Scolyer has died. In his final message he urged all Australians to "pursue ...

A simple change in meal timing may help improve outcomes for women with the most common and aggressive form of ovarian cancer ...

A second dendritic cell vaccine has received fast track designation from the Food and Drug Administration. The Food and Drug Administration (FDA) has granted a fast track designation to a dendritic ...

New research in the January 2023 issue of Journal of the National Comprehensive Cancer Network finds that immunotherapy from immune checkpoint (PD-1) inhibitors prior to surgery was strikingly ...

The Fast Company Impact Council is an invitation-only membership community of top leaders and experts who pay dues for access to peer learning, thought leadership, and more. BY Jurgi Camblong Cancer ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. An oncology student has shocked TikTok with a viral video that offers a ...

A research team in the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has conducted a pioneering study that found an association ...